S'abonner

Idiopathic pulmonary fibrosis is more strongly associated with coronary artery disease than chronic obstructive pulmonary disease - 20/04/23

Doi : 10.1016/j.rmed.2023.107195 
Kevin Bray a, Sandeep Bodduluri b, c, Young-il Kim d, Vivek Sthanam b, c, Hrudaya Nath e, Surya P. Bhatt b, c,
a University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA 
b Division of Pulmonary, Allergy, & Critical Care Medicine, University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA 
c UAB Lung Imaging Lab, University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA 
d Department of Preventive Medicine, University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA 
e Department of Radiology, University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL, USA 

Corresponding author. University of Alabama at Birmingham, Division of Pulmonary, Allergy and Critical Care Medicine, THT 422, 1720, 2nd Avenue South, Birmingham, AL, 35294, USA.University of Alabama at BirminghamDivision of PulmonaryAllergy and Critical Care MedicineTHT 42217202nd Avenue SouthBirminghamAL35294USA

Abstract

Introduction

Previous studies have shown that the population attributable risk of low forced expiratory volume in one second (FEV1) for coronary artery disease (CAD) is substantial. FEV1 can be low either because of airflow obstruction or ventilatory restriction. It is not known if low FEV1 arising from spirometric obstruction or restriction are differently associated with CAD.

Methods

We analyzed high resolution computed tomography (CT) scans acquired at full inspiration in lifetime non-smoker adults with no lung disease (controls) and those with chronic obstructive pulmonary disease enrolled in the Genetic Epidemiology of COPD (COPDGene) study. We also analyzed CT scans of adults with idiopathic pulmonary fibrosis (IPF) from a cohort of patients attending a quaternary referral clinic. Participants with IPF were matched 1:1 by FEV1 %predicted to adults with COPD and 1:1 by age to lifetime non-smokers.

Coronary artery calcium (CAC), a surrogate for CAD, was measured by visual quantification on CT using the Weston score. Significant CAC was defined as Weston score ≥7. Multivariable regression models were used to test the association of the presence of COPD or IPF with CAC, with adjustment for age, sex, body-mass-index, smoking status, hypertension, diabetes mellitus, and hyperlipidemia.

Results

We included 732 subjects in the study; 244 with IPF, 244 with COPD, and 244 lifetime non-smokers. The mean (SD) age was 72.6 (8.1), 62.6 (7.4), and 67.3 (6.6) years, and median (IQR) CAC was 6 (6), 2 (6), and 1 (4), in IPF, COPD, and non-smokers, respectively. On multivariable analyses, the presence of COPD was associated with higher CAC compared to non-smokers (adjusted regression coefficient, β = 1.10 ± SE0.51; P = 0.031). The presence of IPF was also associated with higher CAC compared to non-smokers (β = 03.43 ± SE0.41; P < 0.001). The adjusted odds ratio for having significant CAC was 1.3, 95% CI 0.6 to 2.8; P = 0.53 in COPD and 5.6, 95% CI 2.9 to 10.9; P < 0.001 in IPF, compared to non-smokers. In sex stratified analyses, these associations were mainly noted in women.

Conclusion

Adults with IPF displayed higher coronary artery calcium than those with COPD after accounting for age and lung function impairment.

Le texte complet de cet article est disponible en PDF.

Highlights

Coronary artery disease is the 2nd leading cause of death in both IPF and COPD.
IPF and COPD are associated with higher coronary calcium compared to non-smokers.
IPF confers a greater risk of CAD compared to COPD.
Clinicians should evaluate for and treat CAD following a diagnosis of IPF and COPD.

Le texte complet de cet article est disponible en PDF.

KeyWords : Coronary artery calcium, Idiopathic pulmonary fibrosis, Chronic obstructive pulmonary disease


Plan


© 2023  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 211

Article 107195- mai 2023 Retour au numéro
Article précédent Article précédent
  • Small airways disease in patients with alpha-1 antitrypsin deficiency
  • Dimitrios Toumpanakis, Omar S. Usmani
| Article suivant Article suivant
  • Pneumothorax in hospitalized COVID-19 patients with severe respiratory failure: Risk factors and outcome
  • B. Ragnoli, T. Cena, A. Radaeli, P. Pochetti, L. Conti, A. Calareso, J. Morjaria, Mario Malerba

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.